#MeetTheTeam Jie Luo, Ph.D., OnQuality’s Chief Scientific Officer and co-founder is an associate professor at Shanghai Jiao Tong University. She was involved in developing our propriety AI-enabled drug discovery platform (CARE).
Learn more about our team: onqualityrx.com/who-we-are
Researchers have developed an #AI model that could help doctors know when patients are likely to develop side effects so they can prescribe therapies such as the ones OnQuality is developing to prevent side effects before they develop.
genengnews.com/artificial-in…
November is #NationalHealthSkinMonth. OnQuality is developing first-in-disease therapies in the emerging area of oncodermatology, or the management of skin toxicities caused by cancer therapies.
Learn more about our platforms: onqualityrx.com/diseases-and…
November is #LungCancerAwarenessMonth. Lung cancer patients are commonly treated with anti-cancer agents that cause high rates of skin and GI-toxicities, which OnQuality is developing treatments for.
Learn more @LungAssociation:
lung.org/lung-force/about-lu…
OnQuality’s CEO, Mike McCullar, Ph.D., is guest-lecturing at @UOPacific’s ‘Design Thinking for Entrepreneurs', a course for scientists who want to transition into entrepreneurship.
Our team presented data at the 34th EORTC-NCI-AACR symposium on our pre-clinical research for therapies to prevent chemotherapy-induced diarrhea and skin toxicity.
Read more about our research: onqualityrx.com/post/onquali…
OnQuality’s CEO Mike McCullar, Ph.D., spoke at the Oncodermatology & Cutaneous Oncology Forum at the 2022 Fall Clinical Dermatology Conference.
We’re excited to announce we’ve enrolled the first patient in the second part of our Phase 2 NOVA-II trial for our lead compound OQL011, a treatment for VEGFR inhibitor-induced hand-foot skin reaction.
Read more here: onqualityrx.com/post/onquali…
Happy International #Podcast day! OnQuality’s leadership has been featured on a number of podcasts, including Conversations Life Sciences Leaders Aren’t Having with Jeff Harmon. Give it a listen if you haven’t gotten a chance to yet!
brilliancewithincoaching.com…
A survey of oncologists found that 98% would use a novel therapy to treat EGFR Inhibitor-induced skin toxicity. 77% report that they’ve interrupted #cancer #therapy because of severe skin toxicity.
Read more here: meetings.asco.org/abstracts-…
A recent study found that doctors underestimate #cancer #therapy side effects and caregivers overestimate them, making appropriate treatment difficult.
Read here: medicalxpress.com/news/2022-…
#Metastatic #BreastCancer is when cancer spreads from the breasts to other organs and tissues.
OnQuality is working hard to develop treatments for the side effects of cancer therapies.
Read more about our science here: onqualityrx.com/diseases-and…
OnQuality is presenting preclinical data for two of our candidates at EORTC-NCI-AACR. Both therapies are designed as targeted supportive therapies to prevent the side effects of anti-cancer agents.
Read more about the posters: onqualityrx.com/post/onquali…
#Exercising can be really hard, especially when you’re feeling sick, but studies have shown that it can reduce the severity of the side effects of #cancer treatments.
Read here:
healio.com/news/hematology-o…
#ICYMI - OnQuality was featured in a wonderful @GENbio article from @AlexWestchester. In it, our CEO and CMO discuss the importance of cancer supportive therapies in detail.
Read here: genengnews.com/topics/cancer…
#BreastCancer is a terrible condition where certain side effects of the treatments can be just as bad as the disease
At OnQuality, we’re looking to change that by developing therapies to prevent and treat the side effects of cancer therapies
Read more:
onqualityrx.com/innovation
Treatments for thyroid #cancer can cause skin rashes, often so severe doctors have to stop treatment
We’re working on therapies for this and other side effects to improve the #qualityoflife for #thyroidcancer #patients
Learn more about thyroid cancer: aacr.org/patients-caregivers…
A recent study found that #cancer #patients may be genetically predisposed to adverse effects from #immunotherapies, which means it may be possible to predict patients’ reactions to therapies and to avoid treatments that trigger the worst #sideeffects
news-medical.net/news/202207…
Currently, there are very few treatments available for #cancer #patients that suffer from immunotherapy-induced skin toxicities
OnQuality is working hard to fill this unmet need with therapies to treat this potentially serious condition
Read more here: onqualityrx.com/diseases-and…
